Descripción de negocio
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally.
Consejo de gestión & Consejo de supervisión
| CEO |
| Stephen S. Schwartz |
| Consejo de gestión |
| Herman Cueto, Jason W. Joseph, John O'Brien, Michael Paulo, Olga Pirogova, Luc Provost, Robin Vacha, David Wang, Rob Woodward, Ginger Zhou |
| Consejo de supervisión |
| Frank E. Casal, Edward P. Bousa, Robyn C. Davis, Didier Hirsch, Martin D. Madaus, Erica J. McLaughlin, Tina S. Nova, Michael Rosenblatt |
Datos de la empresa
| Nombre: |
Azenta Inc |
| Dirección: |
200 Summit Drive 6th Floor,Burlington, Massachusetts 01803 |
| Teléfono: |
+1-978-262-2626 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.azenta.com/ |
| Industria: |
Healthcare |
| Sector: |
Medical Products |
| Subsector: |
Medical Supplies |
| Fin del año financiero: |
30/09 |
| Acciones de libre circulación: |
- |
| Fecha de OPI: |
- |
Relación con inversores
| Nombre: |
Sara Silverman |
| IR teléfono: |
+1-877-373-6374 |
| IR-fax: |
- |
| IR e-mail: |
ir@azenta.com
|
